J&J woos Mer­ck­'s Math­ai Mam­men to helm of phar­ma R&D, Hait takes over on ex­ter­nal in­no­va­tion

J&J is ex­e­cut­ing a change­up in the lead­er­ship of its multi­bil­lion-dol­lar R&D group.

The phar­ma gi­ant, which re­cent­ly sig­naled plans to ex­pand its drug pipeline …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER